Clinical Trials: Evidence And Design

Different clinical study designs provide varying levels of evidence. Learn how to evaluate the strength of evidence from clinical trials and how this evidence is used to underpin evidence-based medicine, regulation of therapeutic goods and health policy. About this micro-credential Clinical trials are an essential tool for establishing the safety and efficacy of medical treatments and are integral to evidence-based medicine and the regulation of therapeutic goods. Understanding how to interpret clinical evidence is important for a range of professions in pharmaceutical, clinical practice and health research and policy fields. In this micro-credential, participants will learn to identify different trial designs along with their advantages and limitations and develop skills in the interpretation of evidence from clinical trials. They will also learn how this evidence is used for drug development, clinical care and the approval of therapeutic goods. Key benefits of this micro-credential This micro-credential aligns with the 2 credit point subject, Clinical Trials: Evidence and Design (60002) in one of the following postgraduate offerings: Master of Science (C04241) or Master of Medical Biotechnology (C04390). This micro-credential may qualify for recognition of prior learning at this and other institutions. Who should do this micro-credential? Anyone with an interest in the clinical trials sector would benefit from this micro-credential, and in particular, science and medical graduates, medical researchers and allied health professionals who wish to learn more about the clinical trials process and how the evidence from clinical trials is implemented. Course learning objectives Understand the context of clinical trials and why they are used Identify different types of trial design and list the advantages and limitations of each Evaluate evidence from clinical trials with reference to the study design, reported statistics and study objectives Describe how evidence from clinical trials can be translated into treatments, policy and clinical guidelines.